advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (9)
Showing records 1 to 9
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation24763 Brimonidine purite solution for open-angle glaucoma or ocular hypertension
Batiste CG; Myers J; Katz LJ
Expert Review of Ophthalmology 2008; 3: 513-515
24645 Betaxolol hydrochloride ophthalmic suspension 0.25% and timolol gel-forming solution 0.25% and 0.5% in pediatric glaucoma: A randomized clinical trial
Plager DA; Whitson JT; Netland PA; Vijaya L; Sathyan P; Sood D; Krishnadas SR; Robin AL; Gross RD; Scheib SA
Journal of AAPOS 2009; 13: 384-390
24670 Different concepts of drug delivery in disease entities
Serafin A; Stanczak A
Mini Reviews in Medicinal Chemistry 2009; 9: 481-497
24757 Drug delivery systems for the eye
Kearns VR; Williams RL
Expert Review of Medical Devices 2009; 6: 277-290
24663 Antiglaucoma drops--with or without preservatives
Zemba M
Oftalmologia 2009; 1990
24861 Xal-Ease(R): impact of an ocular hypotensive delivery device on ease of eyedrop administration, patient compliance, and satisfaction
Nordmann JP; Baudouin C; Bron A; Denis P; Rouland JF; Sellem E; Renard JP
European Journal of Ophthalmology 2009; 19: 949-956
24597 A medical device/drug delivery system for treatment of glaucoma
Schultz CL; Poling TR; Mint JO
Clinical and Experimental Optometry 2009; 92: 343-348
24764 Preservatives in topical ophthalmic medications: Historical and clinical perspectives
Freeman PD; Kahook MY
Expert Review of Ophthalmology 2009; 4: 59-64
24664 Effects of preservatives in anti-glaucoma agents on the ocular surface
Potop V
Oftalmologia 2009; 1990
